SAVE Moms and Babies Act of 2026
Sponsored By: Senator Cindy Hyde-Smith
Introduced
Summary
Bans FDA approval of abortion drugs and imposes tight federal controls on their use. This bill would bar the FDA from approving new marketing applications or investigational exemptions for drugs intended to end pregnancies, and it would restrict how already-approved products are labeled, dispensed, and tracked.
Show full summary
- Pregnant people and families would face narrower access. Existing abortion drugs could not be relabeled for use after 70 days gestation and would be limited to in-person administration in clinics, medical offices, or hospitals, not pharmacies.
- Health care practitioners would face new certification and care requirements. Prescribers must be certified, cannot act in the role of a pharmacist, must accurately date pregnancies, diagnose ectopic pregnancies, provide or arrange surgical care and access to transfusion and resuscitation, and obtain patient acknowledgments of risks.
- Manufacturers, researchers, and reporters would face strict limits and reporting rules. New investigational uses would be barred, any pre-enactment investigational exemption would end after 3 years if then prohibited, and manufacturers and prescribers must report adverse events and deaths to the FDA and manufacturers using non-identifiable references and package serial numbers. The bill also preserves state authority to impose additional abortion-drug restrictions.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 0 benefits, 1 costs, 1 mixed.
Ban on abortion drug approvals and trials
If enacted, the bill would bar the FDA from approving any new marketing applications or generic approvals for drugs intended to cause abortions. It would also bar FDA investigational exemptions for abortion drugs or studies that knowingly destroy an unborn child. Investigational exemptions granted before enactment would be deemed rescinded three years after enactment if the Secretary would then be barred from issuing them.
Strict rules for approved abortion drugs
If enacted, the bill would impose strict safety rules on any abortion drug with FDA approval on the enactment date. Prescribers would need certification and specific clinical skills, and the drug could only be given in person by the prescribing practitioner at a clinic, office, or hospital. Labeling could not be changed to allow use after 70 days of gestation or to allow pharmacy or remote dispensing. Manufacturers and prescribers would have to report known adverse events to FDA and the manufacturer without patient names, and other health workers would also have to report adverse events to FDA. The bill would define key terms used for these rules, such as "abortion drug," "adverse event," and "gestation."
Sponsors & CoSponsors
Sponsor
Cindy Hyde-Smith
MS • R
Cosponsors
Sen. Daines, Steve [R-MT]
MT • R
Sponsored 1/27/2026
Sen. Risch, James E. [R-ID]
ID • R
Sponsored 1/27/2026
Mike Rounds
SD • R
Sponsored 1/27/2026
Roger Wicker
MS • R
Sponsored 1/27/2026
Sen. Lankford, James [R-OK]
OK • R
Sponsored 1/27/2026
Sen. McConnell, Mitch [R-KY]
KY • R
Sponsored 1/27/2026
Sen. Lummis, Cynthia M. [R-WY]
WY • R
Sponsored 1/27/2026
Sen. Cruz, Ted [R-TX]
TX • R
Sponsored 1/27/2026
Sen. Banks, Jim [R-IN]
IN • R
Sponsored 1/27/2026
Sen. Marshall, Roger [R-KS]
KS • R
Sponsored 1/27/2026
Katie Britt
AL • R
Sponsored 1/27/2026
Sen. Scott, Rick [R-FL]
FL • R
Sponsored 1/27/2026
Sen. Hawley, Josh [R-MO]
MO • R
Sponsored 1/27/2026
Sen. Crapo, Mike [R-ID]
ID • R
Sponsored 1/27/2026
Sen. Budd, Ted [R-NC]
NC • R
Sponsored 1/27/2026
Sen. Graham, Lindsey [R-SC]
SC • R
Sponsored 1/27/2026
Sen. Cassidy, Bill [R-LA]
LA • R
Sponsored 1/27/2026
Sen. Cornyn, John [R-TX]
TX • R
Sponsored 1/27/2026
Sen. Ernst, Joni [R-IA]
IA • R
Sponsored 1/27/2026
Sen. Lee, Mike [R-UT]
UT • R
Sponsored 1/27/2026
Sen. Cramer, Kevin [R-ND]
ND • R
Sponsored 1/27/2026
Sen. Ricketts, Pete [R-NE]
NE • R
Sponsored 1/27/2026
Sen. Fischer, Deb [R-NE]
NE • R
Sponsored 1/27/2026
Sen. Kennedy, John [R-LA]
LA • R
Sponsored 1/27/2026
John Hoeven
ND • R
Sponsored 1/27/2026
Sen. Young, Todd [R-IN]
IN • R
Sponsored 1/27/2026
Bill Hagerty
TN • R
Sponsored 1/27/2026
Sen. Cotton, Tom [R-AR]
AR • R
Sponsored 1/27/2026
Sen. Moran, Jerry [R-KS]
KS • R
Sponsored 1/27/2026
Sen. Blackburn, Marsha [R-TN]
TN • R
Sponsored 1/27/2026
Sen. Barrasso, John [R-WY]
WY • R
Sponsored 3/25/2026
Sen. Tuberville, Tommy [R-AL]
AL • R
Sponsored 4/27/2026
Sen. Thune, John [R-SD]
SD • R
Sponsored 5/13/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov